Impaired glucose tolerance or newly diagnosed diabetes mellitus diagnosed during admission adversely affects prognosis after myocardial infarction: An observational study

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  George, Anish ^a   Bhatia, Raghav T ^b   Buchanan, Gill L ^a   Whiteside, Anne ^a   Moisey, Robert S ^c   Beer, Stephen F ^a   Chattopadhyay, Sudipta ^a   Sathyapalan, Thozhukat ^d   John, Joseph ^b  

^a SCUNTHORPE GENERAL HOSPITAL   (United Kingdom)

^b CASTLE HILL HOSPITAL   (United Kingdom)

^c CALDERDALE AND HUDDERSFIELD NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; EVENT FREE SURVIVAL; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PROGNOSIS; RETROSPECTIVE STUDY; ANALYSIS; BLOOD; COMPLICATION; DIABETES COMPLICATIONS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; MIDDLE AGED; MYOCARDIAL INFARCTION; PREVALENCE; PROPORTIONAL HAZARDS MODEL; TREATMENT OUTCOME;

ADULT; AGED; BLOOD GLUCOSE; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT ADMISSION; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84957109882     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0142045     Document Type: Article

References (34)

1. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002, 359:2140-2144. PMID: 12090978
2. Bartnik M, Malmberg K, Hamsten A, Efendic S, Norhammar A, Silveira A, et al. Abnormal glucose tolerance-a common risk factor in patients with acute myocardial infarction in comparison with populationbased controls. J Intern Med 2004, 256:288-297. PMID: 15367171
3. Hashimoto K, Ikewaki K, Yagi H, Nagasawa H, Imamoto S, Shibata T, et al. Glucose intolerance is common in Japanese patients with acute coronary syndrome who were not previously diagnosed with diabetes. Diabetes Care 2005, 28:1182-1186. PMID: 15855586
4. Lenzen M, Ryden L, Ohrvik J, Bartnik M, Malmberg K, Scholte Op RW, et al. Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. Eur Heart J 2006, 27:2969-2974. PMID: 17090612
5. Stranders I, Diamant M, van Gelder RE, Spruijt HJ, Twisk JW, Heine RJ, et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 2004, 164:982-988. PMID: 15136307
6. Norhammar AM, Ryden L, Malmberg K. Admission plasma glucose. Independent risk factor for longterm prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 1999, 22: 1827-1831. PMID: 10546015
7. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 2002, 40:1748-1754. PMID: 12446057
8. Bolk J, van der PT, Cornel JH, Arnold AE, Sepers J, Umans VA. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 2001, 79:207-214. PMID: 11461743
9. Bellodi G, Manicardi V, Malavasi V, Veneri L, Bernini G, Bossini P, et al. Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol 1989, 64:885-888. PMID: 2801556
10. Leor J, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Behar S. Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. SPRINT Study Group. Am J Med 1993, 94:265-273. PMID: 8452150
11. Sinnaeve PR, Steg PG, Fox KA, Van de WF, Montalescot G, Granger CB, et al. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-STsegment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events. Arch Intern Med 2009, 169:402-409. doi: 10.1001/archinternmed.2008.572 PMID: 19237725
12. Suleiman M, Hammerman H, Boulos M, Kapeliovich MR, Suleiman A, Agmon Y, et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation 2005, 111:754-760. PMID: 15699267
13. O'Sullivan JJ, Conroy RM, Robinson K, Hickey N, Mulcahy R. In-hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction. Diabetes Care 1991, 14:758-760. PMID: 1954815
14. Otten R, Kline-Rogers E, Meier DJ, Dumasia R, Fang J, May N, et al. Impact of pre-diabetic state on clinical outcomes in patients with acute coronary syndrome. Heart 2005, 91:1466-1468. PMID: 16230445
15. Bartnik M, Malmberg K, Norhammar A, Tenerz A, Ohrvik J, Ryden L. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J 2004, 25:1990-1997. PMID: 15541834
16. Tamita K, Katayama M, Takagi T, Akasaka T, Yamamuro A, Kaji S, et al. Impact of newly diagnosed abnormal glucose tolerance on long-term prognosis in patients with acute myocardial infarction. Circ J 2007, 71:834-841. PMID: 17526977
17. Kitada S, Otsuka Y, Kokubu N, Kasahara Y, Kataoka Y, Noguchi T, et al. Post-load hyperglycemia as an important predictor of long-term adverse cardiac events after acute myocardial infarction: a scientific study. Cardiovasc Diabetol 2010, 9:75. doi: 10.1186/1475-2840-9-75 PMID: 21070650
18. Hofsten DE, Logstrup BB, Moller JE, Pellikka PA, Egstrup K. Abnormal glucose metabolism in acute myocardial infarction: influence on left ventricular function and prognosis. JACC Cardiovasc Imaging 2009, 2:592-599. doi: 10.1016/j.jcmg.2009.03.007 PMID: 19442946
19. Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Muller C, et al. Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study. BMC Endocr Disord 2011, 11:14. doi: 10.1186/1472-6823-11-14 PMID: 21801387
20. Mazurek M, Kowalczyk J, Lenarczyk R, Zielinska T, Sedkowska A, Pruszkowska-Skrzep P, et al. The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively. Cardiovasc Diabetol 2012, 11:78. doi: 10.1186/1475-2840-11-78 PMID: 22741568
21. Ryden L, Standl E, Bartnik M, Van den BG, Betteridge J, de Boer MJ, et al. Guidelines on diabetes, prediabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007, 28:88-136. PMID: 17220161
22. Van de WF, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008, 29:2909-2945. doi: 10.1093/eurheartj/ehn416 PMID: 19004841
23. Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, et al. ESC Guidelines on diabetes, pre-diabetes and cardiovascular diseases developed in collaboration with EASD: the task force on diabetes, pre-diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 2013, 34(39):3035-87. doi: 10.1093/eurheartj/eht108 PMID: 23996285
24. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Eur Heart J 2007, 28:2525-2538. PMID: 17951287
25. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Diabetes Care 1997, 20:1183-1197. PMID: 9203460
26. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167. PMID: 14578255
27. The DECODE Study Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001, 161:397-405. PMID: 11176766
28. Timmer JR, Hoekstra M, Nijsten MW, van dH I, Ottervanger JP, Slingerland RJ, et al. Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention. Circulation 2011, 124:704-711. doi: 10.1161/CIRCULATIONAHA.110.985911 PMID: 21768543
29. Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Arnesen H, et al. Abnormal glucose regulation in patients with acute ST-elevation myocardial infarction-a cohort study on 224 patients. Cardiovasc Diabetol 2009, 8:6. doi: 10.1186/1475-2840-8-6 PMID: 19183453
30. Wallander M, Malmberg K, Norhammar A, Ryden L, Tenerz A. Oral glucose tolerance test: a reliable tool for early detection of glucose abnormalities in patients with acute myocardial infarction in clinical practice: a report on repeated oral glucose tolerance tests from the GAMI study. Diabetes Care 2008, 31:36-38. PMID: 17909086
31. Tenerz A, Norhammar A, Silveira A, Hamsten A, Nilsson G, Ryden L, et al. Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes. Diabetes Care 2003, 26:2770-2776. PMID: 14514578
32. Hage C, Malmberg K, Ryden L, Wallander M. The impact of infarct type on the reliability of early oral glucose tolerance testing in patients with myocardial infarction. Int J Cardiol 2010, 145:259-260. doi: 10.1016/j.ijcard.2009.09.469 PMID: 19850366
33. Avezum A, Makdisse M, Spencer F, Gore JM, Fox KA, Montalescot G, et al. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2005, 149:67-73. PMID: 15660036
34. Mandelzweig L, Battler A, Boyko V, Bueno H, Danchin N, Filippatos G, et al. The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J 2006, 27:2285-2293. PMID: 16908490